Bioactive Goniothalamin from Goniothalamus tapis with Cytotoxic Potential
Kallaya Sangrueng1, Saksri Sanyacharernkul2, Sirinapa Nantapap2, Narong Nantasaen3 & Wilart Pompimon4 Show affiliations
- Phranakhon Rajabhat University, Thailand
- Chiang Mai University, Thailand
- Ministry of Natural Resources and Environment, Thailand
- Lampang Rajabhat University, Thailand
American Journal of Applied Sciences, Volume 12, Issue 9, pp. 650–653 · doi.org/10.3844/ajassp.2015.650.653
Abstract
Goniothalamus (Annonaceae) is well known for the rich of styryllactone contents and these plants are famous for the potential to be applied as alternative biological activities. The chemical and biological investigations of Goniothalamus tapis is tested for anticancer activities. The research was processioned to extract, isolate, purify and elucidate structure from the leaves and twigs of G. tapis. The isolated compound was evaluated with cytotoxic activity. Goniothalamin was isolated from ethyl acetate extract of G. tapis and the spectroscopic techniques were used for structure elucidation. In addition, goniothalamin was the most powerful to cytotoxic activity which was the first reported for this specie. The goniothalamin was possessed a potent cytotoxicity. Therefore, it is possible to use this compound as a pharmacological agent.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 3.0 Licence (CC BY 3.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Sangrueng, K., Sanyacharernkul, S., Nantapap, S., Nantasaen, N. & Pompimon, W. (2015). Bioactive Goniothalamin from Goniothalamus tapis with Cytotoxic Potential. American Journal of Applied Sciences, 12(9), 650–653. https://doi.org/10.3844/ajassp.2015.650.653
- Licence
- CC BY 3.0
- Issue
- Volume 12, Issue 9
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
